The four staining patterns of CRABP-II and FABP5 were observed among glioblastomas: CRABP-II−/FABP5−, CRABP-II−/FABP5+, CRABP-II+/FABP5− and CRABP-II+/FABP5+ and the respective profiles were expressed by 18% (2/11), 18% (2/11), 37% (4/11) and 27% (3/11) of the glioblastomas (Figure 1B). This evidence concerns the gene FABP5 and glioblastoma.